Orgenesis Statistics
Total Valuation
Orgenesis has a market cap or net worth of 8.74 million. The enterprise value is 25.80 million.
| Market Cap | 8.74M |
| Enterprise Value | 25.80M |
Important Dates
The next estimated earnings date is Thursday, April 10, 2025.
| Earnings Date | Apr 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Orgenesis has 5.17 million shares outstanding. The number of shares has increased by 32.75% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 5.17M |
| Shares Change (YoY) | +32.75% |
| Shares Change (QoQ) | +21.34% |
| Owned by Insiders (%) | 10.76% |
| Owned by Institutions (%) | 4.16% |
| Float | 4.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.96 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.75 |
| EV / Sales | 28.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.64 |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.10 |
| Interest Coverage | -8.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -68.49% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 6,158 |
| Profits Per Employee | -235,699 |
| Employee Count | 146 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.13% in the last 52 weeks. The beta is 1.10, so Orgenesis's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -40.13% |
| 50-Day Moving Average | 1.41 |
| 200-Day Moving Average | 4.40 |
| Relative Strength Index (RSI) | 50.76 |
| Average Volume (20 Days) | 15,838 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.20 |
Income Statement
In the last 12 months, Orgenesis had revenue of 899,000 and -34.41 million in losses. Loss per share was -9.29.
| Revenue | 899,000 |
| Gross Profit | -878,000 |
| Operating Income | -25.87M |
| Pretax Income | -35.35M |
| Net Income | -34.41M |
| EBITDA | -24.05M |
| EBIT | -25.87M |
| Loss Per Share | -9.29 |
Balance Sheet
The company has 204,000 in cash and 17.30 million in debt, giving a net cash position of -17.09 million or -3.31 per share.
| Cash & Cash Equivalents | 204,000 |
| Total Debt | 17.30M |
| Net Cash | -17.09M |
| Net Cash Per Share | -3.31 |
| Equity (Book Value) | -23.93M |
| Book Value Per Share | -5.01 |
| Working Capital | -33.53M |
Cash Flow
In the last 12 months, operating cash flow was -15.48 million and capital expenditures -263,000, giving a free cash flow of -15.74 million.
| Operating Cash Flow | -15.48M |
| Capital Expenditures | -263,000 |
| Free Cash Flow | -15.74M |
| FCF Per Share | -3.05 |
Margins
| Gross Margin | -97.66% |
| Operating Margin | -2,877.75% |
| Pretax Margin | -3,931.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Orgenesis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.75% |
| Shareholder Yield | -32.75% |
| Earnings Yield | -549.80% |
| FCF Yield | -180.21% |
Stock Splits
The last stock split was on September 25, 2024. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Orgenesis has an Altman Z-Score of -13.59. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.59 |
| Piotroski F-Score | n/a |